Jeffrey Miller, MD
Pain Medicine · Moore, OKNPI 1508905704
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 78.3% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2023 at $12,131 and has fallen 72.3% since, to $3,365 in 2025. Among pain medicine clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 449 payments — averaging $74.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$26K
- Abbott$2K
- Forte Bio-pharma LLC$1K
- BD$850
- Saluda Medical Americas, Inc.$682
- AbbVie$613
- plus $2K from 23 others
What the payments were for
- Speaking & faculty fees$17,90054%
- Travel & lodging$2,9609%
- Food & beverage$12,50137%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 159 | $26,110 |
| Abbott | 51 | $1,551 |
| Forte Bio-pharma LLC | 76 | $1,104 |
| BD | 1 | $850 |
| Saluda Medical Americas, Inc. | 20 | $682 |
| AbbVie(2 entities) | 52 | $613 |
| Boston Scientific | 6 | $337 |
| Nevro Corp. | 7 | $316 |
| Globus Medical | 4 | $267 |
| Spinal Simplicity, LLC | 4 | $230 |
| Collegium Pharmaceutical, Inc. | 11 | $189 |
| Si-bone, Inc. | 2 | $151 |
| Amgen | 12 | $142 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $131 |
| Pfizer | 5 | $80 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $80 |
| Lilly USA, LLC | 5 | $77 |
| Vertex | 3 | $76 |
| SPR Therapeutics, Inc | 3 | $70 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| Biodelivery Sciences International, Inc. | 3 | $46 |
| Nalu Medical, Inc. | 2 | $42 |
| Zimmer Biomet | 2 | $41 |
| Scilex Pharmaceuticals Inc. | 2 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| GRT US Holding, Inc. | 1 | $20 |
| Tonix Medicines, Inc. | 1 | $20 |
| Stimwave Technologies Incorporated | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VANTA ADAPTIVESTIM$9,314
- OSTEOCOOL RF ABLATION$2,450
- INTELLIS$2,329
- SYNCHROMED$2,212
- RESTORE$2,100
- Prolate$1,948
- INTELLIS ADAPTIVESTIM$1,600
- SYNCHROMEDII$1,400
- INCEPTIV$793
- KYPHON EXPRESS II KYPHOPAK TRAY$572
- Nalocet$521
- Evoke$360
- PROCLAIM$263
- Senza$257
- Neuromodulation Dspsbls and Accs$230
- Proclaim Family of SCS IPGs$172
- HA MINUTEMAN G3-R$167
- TARGETSTIM$160
- SPECTRA WAVEWRITER$144
- TANLOR$136
How this compares
$33,361 in reported general payments places this provider in the 90th percentile of 68 pain medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,304 | $301,538 |
| Buprenorphine | 433 | $91,429 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,229 | $62,010 |
| PercocetOxycodone Hcl/Acetaminophen | 12 | $52,235 |
| BelbucaBuprenorphine Hcl | 61 | $44,164 |
| Xtampza ErOxycodone Myristate | 81 | $31,893 |
| OxycontinOxycodone Hcl | 66 | $26,573 |
| Nucynta ErTapentadol Hcl | 24 | $22,336 |
| Oxycodone Hcl | 842 | $17,952 |
| Pregabalin | 616 | $14,384 |
| Morphine Sulfate ErMorphine Sulfate | 360 | $8,314 |
| Hysingla ErHydrocodone Bitartrate | 14 | $5,391 |
| ButransBuprenorphine | 16 | $5,185 |
| Buprenorphine Hcl | 168 | $4,555 |
| Fentanyl | 53 | $4,200 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta Er | $189 | $98,393166 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 68 pain medicine providers in Oklahoma.
Other pain medicine in Moore
- Sailesh ArulkumarOklahoma City$162K
- Emily PollardOklahoma City$134K
- James StephensNorman$39K
- Tyler PhillipsOklahoma City$36K
- Nevinson SamEdmond$27K
- John NelsonOklahoma City$26K
- Rafael JustizOklahoma City$25K
- Bruce MackeyEdmond$14K
- Brian TorgersonTulsa$13K
- Lam NguyenTulsa$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.